Registry for patients with severe asthma in Canada

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The International Severe Asthma Registry aims to improve the care of individuals with severe asthma by collecting detailed health and treatment information from participants over five years. This observational study will gather anonymized longitudinal data through medical chart reviews and participant interviews at multiple Canadian sites. The collected data will help researchers understand severe asthma better and develop improved treatment strategies. Participants will be followed annually to track their progress and treatment responses.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants 18 years or older
* Participants receiving treatment according to GINA Step 5 or uncontrolled in GINA Step 4 (uncontrolled is defined as having severe asthma symptoms or frequent exacerbations)

Exclusion Criteria:

-Participants with mild to moderate asthma

Where it's running

• University of Alberta
  Edmonton, Alberta, Canada Recruiting
• Synergy MD Specialty Group
  Edmonton, Alberta, Canada Recruiting
• University of British Columbia
  Vancouver, British Columbia, Canada Recruiting
• University of British Columbia
  Vancouver, British Columbia, Canada Recruiting
• Kingston General Hospital
  Kingston, Ontario, Canada Recruiting
• The Ottawa Hospital
  Ottawa, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Celine Bergeron — University of British Columbia
• Study coordinator: Shelley Abercromby
• Email: Shelley.Abercromby@vch.ca
• Phone: (604) 875-4111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Structured physical activity program added to tezepelumab for adults with severe asthma

  A 12-week program to help adults with severe asthma who start tezepelumab see if adding guided physical activity improves activity levels and chances of remission.

  Recruiting University of Leeds · Leeds · NCT07735494

• Exercise program for adults with severe asthma starting biologics

  A tailored exercise program is being tested to see if it helps adults with severe asthma who are starting biologic therapy feel better and breathe better.

  Recruiting Helsinki University Central Hospital · Helsinki · NCT07655037

• Frevecitinib (KN-002) for severe asthma: a 12-week dose-ranging study

  This study tests three doses of frevecitinib vs placebo to see if it helps people with severe asthma not controlled by standard inhaled steroids and LABA therapy.

  Recruiting at 9 sites Phase 2 Kinaset Therapeutics Inc · Lancaster, California and 13 other locations · NCT07532265

• Benralizumab treatment for adults with ABPA and severe asthma

  This will test whether benralizumab helps adults (18–75) who have severe asthma with allergic bronchopulmonary aspergillosis (ABPA).

  Recruiting at 2 sites Qianfoshan Hospital · Jinan, Shandong and 1 other locations · NCT07530770

• Tezepelumab to reduce maintenance medication in people with severe asthma

  This will test whether people aged 12–80 with severe asthma in China who start tezepelumab can safely reduce their regular maintenance medicines while keeping asthma controlled.

  Recruiting at 59 sites Phase 3 AstraZeneca · Beijing and 74 other locations · NCT07363642

• GB-0895 as an add-on treatment for severe uncontrolled asthma in adolescents and adults

  This test tries to see if adding GB-0895 every six months helps adolescents and adults whose severe asthma isn't controlled by inhaled steroids and other controllers.

  Recruiting at 158 sites Phase 3 Generate Biomedicines · Bakersfield, California and 157 other locations · NCT07359846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.